Automated Sample Storage Systems Market Size & Share 2026 - 2034

Automated Sample Storage Systems Market Size

The global automated sample storage systems market size was valued at USD 1.4 billion in 2025. The market is anticipated to grow from USD 1.6 billion in 2026 to USD 3.6 billion in 2034, growing at a CAGR of 11.1% from 2026 to 2034.

This high growth is attributed to several factors including the growing need for biobanking and maintaining biorepositories, digital transformation across clinical and research laboratories, growth in drug discovery and development, and growing focus on sample integrity and compliance.

The Automated Sample Storage Systems Market is gaining momentum as laboratories, biobanks, pharmaceutical companies, and research institutions increasingly prioritize efficient sample management, traceability, and workflow automation. Automated sample storage systems use advanced robotics and automated storage retrieval technologies to securely store, track, and retrieve biological, chemical, and industrial samples with minimal human intervention. These solutions help reduce manual handling errors, improve sample integrity, and accelerate research operations, making them a critical component of modern laboratory infrastructure.

Growing demand for automated biological storage systems is being driven by the rapid expansion of biobanks and large-scale research programs. Organizations managing millions of specimens require high-density automated sample storage and retrieval systems to maintain operational efficiency and regulatory compliance. For instance, Biobank Graz manages approximately 22 million human tissue and body fluid specimens, highlighting the increasing need for automated sample storage systems capable of supporting large-volume sample repositories while optimizing storage space and retrieval speed.

The market is also benefiting from the broader digital transformation of laboratories. As laboratories adopt Laboratory Information Management Systems (LIMS) and connected research platforms, automated sample management solutions are being integrated to enable real-time inventory visibility, automated sample tracking, and seamless workflow coordination. This integration enhances data accuracy and operational efficiency across research environments. Furthermore, ongoing investments in digital laboratory infrastructure, such as Danone’s expansion of its Digital Lab (D-Lab) in Singapore announced in June 2025, underscore the growing emphasis on intelligent laboratory ecosystems. As research organizations continue to modernize operations, demand for automated sample storage, automated sample retrieval systems, and next-generation laboratory automation technologies is expected to accelerate globally.

Automated Sample Storage Systems Market Trends

• The market is expanding rapidly as biobanks, pharmaceutical companies, and research laboratories manage growing volumes of biological samples generated through genomic research, precision medicine, and large-scale clinical studies. Publicly funded initiatives such as UK Biobank and Genome India, along with increasing investments in high-throughput sequencing programs, are accelerating demand for automated sample storage, automated biological storage systems, and advanced automated sample management solutions. These technologies help laboratories maintain sample integrity, maximize storage capacity, and support efficient long-term preservation of valuable biological materials.
• A key trend shaping the market is the integration of artificial intelligence (AI) and machine learning into automated sample storage retrieval systems. AI-powered platforms streamline sample identification, optimize retrieval workflows, reduce operational errors, and provide real-time inventory visibility. As highlighted in recent scientific research, AI and machine learning are increasingly used to analyze complex datasets, predict outcomes, and support clinical decision-making, making automated storage retrieval systems in laboratories an essential component of modern research infrastructure. This capability is particularly valuable in pharmaceutical R&D, genomic diagnostics, and precision medicine applications where speed, accuracy, and traceability are critical.
• Another major advancement is the adoption of intelligent sample tracking technologies, including RFID-enabled identification and high-density 2D barcode systems. These solutions enable rapid, contactless sample verification, improve inventory management, and enhance chain-of-custody documentation across automated sample stores. By automating sample identification, location tracking, and retrieval processes, laboratories can reduce manual intervention, strengthen regulatory compliance, and improve workflow efficiency. As a result, demand for scalable automated sample processing and storage infrastructure continues to grow across biobanks, pharmaceutical research facilities, and academic research centers worldwide. 

Automated Sample Storage Systems Market Analysis

Based on product, the global market is segmented into automated compound storage systems, automated liquid handling systems, and other products. The automated compound storage systems segment accounted for the highest market share and was valued at USD 798.9 million in 2025.
 

• Automated compound storage systems play a crucial role in supporting high-throughput drug discovery and pharmaceutical research. These systems are designed to store and manage large volumes of chemical compounds with precision, speed, and minimal human intervention, which is essential for accelerating screening processes and reducing operational inefficiencies.
   
• The increasing demand for efficient compound management in pharmaceutical and biotech industries, coupled with the growing complexity of drug libraries and the need for reproducibility in research, is driving the growth of the automated compound storage systems market. As per the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), on average, researchers identify one promising compound among 5,000–10,000 screened. In 2022, over 9,000 compounds were at various stages of development globally, highlighting the rising need for effective compound management across pharmaceutical companies.
   
• Additionally, these systems ensure optimal environmental conditions, such as controlled humidity and temperature, to prevent compound degradation and maintain long-term usability and data reliability. This capability is driving the global adoption of automated compound storage systems.

Learn more about the key segments shaping this market

Download Free PDF

Based on the sample, the global automated sample storage systems market is categorized into compound sample, biological sample, and other samples. The compound sample segment dominated the market with 59.3% market share in 2025.
 

• The compound sample segment holds a significant share in the market, driven by the rising need for rapid and high-throughput screening (HTS). HTS processes require efficient retrieval, tracking, and processing of compounds with high precision and speed. Automated systems, featuring integrated robotics, climate control, and inventory management, enhance these workflows, making them critical for pharmaceutical research and development.
   
• As per the 2024 study published by Elsevier Journal, pharmaceutical and biotechnology companies are finding increasing applications of HTS, specifically in repurposing the drugs. As per the study, HTS has been used to screen 100,000 compounds per week and tested in vitro and in vivo for respective disease treatment. As a result, with the growing demand for drug development and rise in HTS screening, the demand for automated sample storage systems is increasing, specifically for managing compound samples.
   
• Additionally, compound samples are often a valuable asset for the pharmaceutical companies. These samples are expensive to synthesize and subject to proprietary protocols. Thus, ensuring their secure and traceable storage is among the key priorities for pharmaceutical companies. Automated systems minimize degradation, prevent contamination, and ensure compliance with regulatory standards, further boosting their adoption for managing compound samples. Further, as drug pipelines expand and personalized medicine advances, the demand for effective compound management continues to grow, reinforcing the dominance of the compound sample segment in the market.
   

Based on end use, the global automated sample storage systems market is classified into pharmaceutical and biotechnology companies, biobanks, academic and research institutes, and other end users. In 2025, the pharmaceutical and biotechnology companies segment held a market share of about 45.4%. The segment is further expected to showcase significant growth over the analysis period.
 

• Pharmaceutical and biotechnology companies dominate the market owing to their extensive need for efficient sample management in research and development activities.
   
• Pharmaceutical and biotechnology companies handle large volumes of high-value samples, requiring secure, traceable, and contamination-free storage solutions. Automated systems enhance operational efficiency by integrating robotics, climate control, and inventory management, ensuring compliance with stringent regulatory standards.
   
• Moreover, the growing focus on personalized medicine and expanding drug pipelines further drives the adoption of these systems. As per IFPMA, the pharmaceutical industries witnessed a significant expansion in their drug pipeline in 2022. About 3,148 medicines related to cancer were under development, followed by 1,677 for immunology, 1,668 for neurology, 1,488 for infectious diseases, and 1,460 for digestive diseases. The ability of automated sample storage systems to minimize errors, reduce sample degradation, and streamline workflows makes them indispensable for pharmaceutical and biotechnology companies, solidifying their leading position among end users.

North America dominated the global automated sample storage systems market in 2025, valued at USD 590.2 million.
 

• The U.S. market size reached USD 523.4 million in 2025. 
• North America has a large number of pharmaceutical and biotechnology companies, in countries such as the U.S. and Canada, that are actively involved in using automated sample storage systems during drug development and clinical trial procedures.
   
• For instance, as per the 2025 article from Cross River Therapeutics, a key provider of applied behavior analysis therapy services, the U.S. hosts over 5,000 pharmaceutical companies, with an annual R&D investment exceeding USD 60 billion. Contributing to approximately 20% of global pharmaceutical R&D activities, the country also has a portfolio of nearly 40,000 FDA-approved drugs. This robust R&D ecosystem positions the pharmaceutical and biotechnology sectors as significant contributors to the growth of the market.
   
• In addition, the region also hosts prominent biobanks such as the Kaiser Permanente (KP) Biobank, one of the largest in the U.S., and the NIH "All of Us" Research Program Biobank (U.S.), which serves as a critical resource for advancing precision medicine research. The presence of crucial biobanks together with rising growth in research and development activities for novel drug development is driving an increasing need for automated sample storage systems in the region, further contributing to its growth.
   

The Europe automated sample storage systems market accounted for USD 416 million in 2025.
 

• Europe holds a significant share in the market, driven by its advanced infrastructure, collaborative research initiatives, and strict biospecimen quality standards. Key countries such as Germany, the United Kingdom, France, and Sweden have made substantial investments in laboratory automation across university hospitals, clinical trial centers, and contract research organizations (CROs), fueling the demand for sophisticated storage solutions. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), Europe experienced a notable 313.3% growth in clinical trials utilizing digital technologies between 2010 and 2021.
   
• Germany is expected to experience significant growth over the forecast period due to its strong growth in pharmaceutical research and development, aging population, and increased investment in laboratory digitalization.
   
• Moreover, initiatives like the European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-ERIC) have been instrumental in standardizing biobanking practices and expanding storage capacities across the region.
   
• Europe’s focus on personalized medicine, pandemic preparedness, and longitudinal health studies has further accelerated the adoption of automated systems that ensure sample integrity, traceability, and compliance with regulatory standards. Additionally, Europe remains a hub for pharmaceutical innovation and manufacturing. As reported by EFPIA, the number of industry-sponsored clinical trials in Europe increased from approximately 1,327 in 2010 to around 1,451 in 2021.
   

The Asia Pacific automated sample storage systems market is anticipated to grow at the highest CAGR of 12% during the analysis timeframe.
 

• Asia Pacific is positioned as the fastest-growing region in the market, driven by expanding research infrastructure, increasing pharmaceutical investments, and the rising adoption of laboratory automation.
   
• Key countries such as China, India, Japan, and South Korea are making significant investments in establishing advanced biobanking facilities and enhancing drug research and development capabilities. For instance, according to an August 2023 study published by Sage Journal, Singapore has implemented the Human Biomedical Research Act of 2015 to regulate human tissue banking with stringent reporting requirements for researchers. Japan hosts three major biobanks, while Vietnam has initiated several biobanking projects focusing on various human diseases, with the Ministry of Health encouraging hospitals to develop biobanking operations. These developments are driving the demand for automated sample storage systems across the Asia Pacific region.
   
• The region’s large population and growing healthcare needs are further fueling demand for advanced diagnostics and personalized medicine, which, in turn, is boosting the adoption of automated storage solutions.
   
• China is anticipated to experience rapid growth during the forecast period due to increasing R&D investments in the pharmaceutical and biotechnology sectors, rising investments in biobanking infrastructure, and growing demand for sample collection and storage during infectious disease outbreaks. According to EFPIA, China’s pharmaceutical R&D investments have been growing at a CAGR of 20.38%.
   
• Additionally, Asia Pacific benefits from increased government and private sector funding for life sciences research, along with regulatory reforms that promote innovation and technology adoption. The region’s cost-effective manufacturing capabilities and rapidly expanding biotechnology sector make it an attractive market for global players seeking growth opportunities.
   

The Latin America automated sample storage systems market was valued at USD 62.6 million in 2025.
 

• Latin America is experiencing notable growth in the market, driven by regulatory compliance requirements, the expansion of the pharmaceutical and biotechnology industries, and the increasing adoption of automation technologies.
   
• Brazil is emerging as a key contributor to this growth, supported by its expanding pharmaceutical manufacturing sector and contract research organizations (CROs). According to the Generics and Biosimilar Initiative (GaBI), Brazil's pharmaceutical market ranks as the third largest in the Americas, following the United States and Canada, and holds the top position in the Latin American region.
• As a result, the demand for automated sample storage solutions across local pharmaceutical companies and CROs is increasing.
   
• Governments across the Latin American region are actively investing in the modernization of healthcare and research infrastructure, including the implementation of advanced storage systems to support clinical trials, diagnostics, and biobanking activities. A January 2025 article published by the Lancet Research Journal highlights significant progress in biobank development and precision medicine in countries such as Brazil, Chile, and Mexico. These nations have established biobanks focusing on research into cancer, metabolic, infectious, and neurological diseases.
   

The Middle East and Africa automated sample storage systems market is expected to grow with a CAGR of about 10.4% during the forecast period.
 

• The automated sample storage market in the Middle East and Africa is being driven by advancements in healthcare infrastructure, increasing investments in research and development, and the growing adoption of automation technologies.
   
• Governments in the Middle East and African region are focusing on modernizing healthcare systems and supporting biobanking initiatives to enhance clinical research and diagnostics. For instance, as per the study published in the National Center for Biotechnology Information, owing to government-backed initiatives such as the National MalariaGen Network, Low and Middle Income Countries Biobank and Cohort Network (BCNet), and Human, Heredity, and Health in Africa (H3Africa) initiative, biorepository science has been bolstered, regional biobanks are springing up, and awareness about biobanks is growing in Africa.
   
• Additionally, the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer in the region is significantly driving the demand for automated sample storage systems. These conditions require long-term monitoring, frequent diagnostic testing, and large-scale biobanking, all of which generate vast volumes of biological samples that must be stored securely and efficiently. Automated systems offer the precision, traceability, and temperature control needed to maintain sample integrity over time, which is critical for accurate diagnostics and research.
   
• The Saudi Arabia market is primarily driven by the increasing demand for advanced healthcare and pharmaceutical research infrastructure, in line with the objectives of Vision 2030. For instance, the Saudi Human Genome Program (SHGP), initiated by King Abdulaziz City for Science and Technology (KACST), is dedicated to sequencing the genomes of the Saudi population to identify genetic variations associated with health conditions and enable the development of personalized medical solutions. Additionally, biobanks are integral to this initiative, facilitating the preservation of genetic samples and the collection of health data to advance genomics research.
   

Automated Sample Storage Systems Market Share

The market is moderately fragmented, with key players such as Brooks Automation, Thermo Fisher Scientific, TTP LabTech, and Hamilton Company competing to strengthen their market presence. These players together contribute to about 55% market share.
 

Established companies are investing in research and development to enhance the efficiency and reliability of their storage systems. Additionally, they are expanding their geographic footprint through collaborations and acquisitions to cater to the growing demand across various regions. The competitive rivalry is further intensified by the increasing adoption of automation in laboratories and biobanks, driving the need for advanced storage solutions.
 

Market participants are also emphasizing customer-centric approaches, offering customized solutions to meet specific end-user requirements. The focus on sustainability and energy-efficient systems is emerging as a key trend, with companies integrating eco-friendly technologies into their product offerings. Overall, the competitive landscape is shaped by innovation, strategic initiatives, and the ability to address evolving customer needs effectively.
 

Automated Sample Storage Systems Market Companies

Few of the prominent players operating in the automated sample storage systems industry include:

• Angelantoni Life Science
• ASKION
• Azenta
• Beckman Coulter
• Biotron Healthcare
• Brooks Automation
• Haier Biomedical
• Hamilton Company
• LiCONiC
• MEGAROBO
• MICRONIC
• Panasonic Healthcare
• SPT Labtech
• Thermo Fisher Scientific
• TTP LabTech
   
• Brooks Automation

Brooks Automation delivers advanced robotic automation and high-capacity storage systems, offering scalability and reliability for large-scale biobanking and laboratory operations. Its solutions are designed to enhance operational efficiency, reduce manual intervention, and ensure the integrity of stored samples, making it a preferred choice for organizations requiring robust and automated sample storage systems.
 

• Thermo Fisher Scientific

Thermo Fisher Scientific offers an extensive range of automated storage systems integrated with advanced software solutions. These systems enable seamless sample tracking, efficient management, and enhanced operational workflows. The company’s focus on innovation and comprehensive offerings makes it one of the key players that addresses the diverse needs of laboratories and biobanks globally.
 

• TTP LabTech

TTP Labtech is recognized for its compact and energy-efficient storage systems, designed to optimize space utilization while maintaining sample integrity. Its solutions cater to laboratories with limited space, offering reliable performance and sustainability. By focusing on user-friendly designs and innovative technologies. TTP Labtech, through its advanced products, addresses the growing demand for efficient and eco-friendly storage systems.

Automated Sample Storage Systems Industry News

• In March 2026, Azenta Life Sciences acquired UK Biocentre Limited for £20.5 million (approximately USD 26 million), including up to £1.8 million in contingent consideration. UK Biocentre generated approximately £15.3 million (approximately USD 19.4 million) in revenue during the 12 months ended September 2025. The acquisition expands Azenta's sample management, storage, and biorepository capabilities across Europe.
• In January 2026, Astoriom acquired Precision Stability Storage to expand its sample management and stability storage operations across North America. While the financial value of the transaction was not publicly disclosed, the acquisition added three storage facilities across North Carolina, Florida, and Massachusetts, significantly increasing Astoriom’s storage capacity and geographic reach for biopharmaceutical and biotechnology clients.
   

The automated sample storage systems market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Click here to Buy Section of this Report

Market, By Product

• Automated compound storage systems
• Automated liquid handling systems
• Other products

Market, By Sample

• Compound sample
• Biological sample
• Other samples

Market, By End Use

• Pharmaceutical and biotechnology companies
• Academic and research institutes
• Biobanks
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE